RT @GringaBrazilien: Estudo de 5700 pacientes em 12 Hospitais de New York apresenta dados chocantes de Mortalidade COVID19: ENTUBADOS ✝️76%…
RT @hvanspall: #COVID19 case series (n=5700 hospitalized in NYC) 🔹median age 63y, 40%F 🔹HTN, obesity, DM common 🔹At triage, only31% febril…
RT @TinyEnergies: The ventilated mortality rate is falsely high given the majority of patients are STILL on ventilators, status pending. Bu…
RT @DrJohnScott: THREAD: Lots of alarm over the 🚨88% Mortality🚨among #Covid19 patients on ventilators. The paper *should* say "Among pts on…
RT @MasuzoeYoichi: 最新の研究では、人工呼吸器を使用のコロナ患者の88.1%が死亡。つまり、人工呼吸器が必要になる前に、アビガンなどの抗ウイルス薬を早期に投与し治療効果を高めねばならないのである。第一線の医者からも、患者の命を救うためにアビガンを使用すべきだと…
RT @bclund: New report on 5700 NYC Covid patients: -94% had MORE than one other disease -Median age 63 -53% had hypertension -42% were obe…
RT @emlitofnote: Findings from hospitalized #covid19 patients through April 4th in NYC: - 2,634 of 5,700 hospitalizations had reached a cl…
RT @DrJohnScott: THREAD: Lots of alarm over the 🚨88% Mortality🚨among #Covid19 patients on ventilators. The paper *should* say "Among pts on…
RT @EricTopol: Fixed link for @JAMA_current @NorthwellHealth paper https://t.co/13CeozQKlU by @SafiyaMD and colleagues
RT @MasuzoeYoichi: 最新の研究では、人工呼吸器を使用のコロナ患者の88.1%が死亡。つまり、人工呼吸器が必要になる前に、アビガンなどの抗ウイルス薬を早期に投与し治療効果を高めねばならないのである。第一線の医者からも、患者の命を救うためにアビガンを使用すべきだと…
Clinical Characteristics, Comorbidities, and Outcomes Among Patients With COVID-19 Hospitalized in the NYC Area https://t.co/H3rBympjR7
Interesting observations from yesterday's COVID-19 NYC paper @JAMA_current: https://t.co/vqujzE3gMX. "Mortality rates for patients with hypertension not taking an ACEi or ARB, taking an ACEi, and taking an ARB were 26.7%, 32.7%, and 30.6%, respectively."
RT @felipea_rc: 5700 pacientes en NY USA La mayoría presentó una primera pcr positiva 1,9% necesito un segundo test para diagnóstico Coin…
RT @DrJohnScott: THREAD: Lots of alarm over the 🚨88% Mortality🚨among #Covid19 patients on ventilators. The paper *should* say "Among pts on…
RT @CMichaelGibson: Outcomes in 5,700 hospitalized patients in New York. Overall mortality was 21%. 88% of those intubated died. https…
RT @onceuponA: I understand that journals are working on tight timetables to publish COVID research, but it boggles the mind that the sente…
RT @IngridKatzMD: Thread: Whoa - this study from @JAMA_current is about as sobering as it gets. Recognize that it is a case series, and the…
Clinical Characteristics, Comorbidities, and Outcomes Among Patients With COVID-19 Hospitalized in the NYC Area https://t.co/6E3FFvNGge
COVID-19、高血圧・肥満・糖尿病の三点セットがやばいのか、統計的に…… https://t.co/vyOIP3rXzh
RT @PACCMUS: Hey @cnn @NewDay @arianaeunjung @washingtonpost reviewing the JAMA paper of 5700 NYC area patients with COVID-19. https://t.co…
RT @DrJohnScott: THREAD: Lots of alarm over the 🚨88% Mortality🚨among #Covid19 patients on ventilators. The paper *should* say "Among pts on…
RT @SaskiaPopescu: And this is why we read the full article and not just the abstract. Thanks for calling out that bad practice @DrJohnScott
RT @TheENDofTHSK: 医療崩壊が進行中のNYで要入院患者の42%がメタボ (BMI≥30)。BMI≥35も19%もいる。その他目立つ既往症は糖尿病34%と高血圧57%。 人工呼吸器を要した患者の致死率は88%…。もはや病院関係者に犠牲を強いてまで医学的処置を行う必…
RT @ACLakeMD: Only 31% of those who were *admitted* with COVID had a fever. Why are we screening people with thermometers everywhere? Is it…
More data on the COVID+ population: no deaths under age 18, 88% mortality for mechanically ventilated patients, >98% for vent+age>65. Clinical Characteristics, Comorbidities, and Outcomes Among Patients With COVID-19 Hospitalized in the NYC Area http
RT @AndyBiotech: #COVID19 Important new data on 5700 hospitalized patients in NYC https://t.co/GiExjs8iFC median age 63 60% male 42% obes…
RT @daltonprice386: [THREAD] Wow. A study published in @JAMA_current today with key numbers about #COVID19 in NYC area, n=5700 and all co…
RT @daltonprice386: [THREAD] Wow. A study published in @JAMA_current today with key numbers about #COVID19 in NYC area, n=5700 and all co…
RT @MasuzoeYoichi: 最新の研究では、人工呼吸器を使用のコロナ患者の88.1%が死亡。つまり、人工呼吸器が必要になる前に、アビガンなどの抗ウイルス薬を早期に投与し治療効果を高めねばならないのである。第一線の医者からも、患者の命を救うためにアビガンを使用すべきだと…
RT @EthanLSanford: These numbers are frightening. 88.1% mortality for intubated pts...21% overall in hospitalized patients..how can we keep…
RT @reginadalmau: Clinical Characteristics, Comorbidities, and Outcomes Among Patients With COVID-19 Hospitalized in the NYC Area https://t…
RT @deep__wreck: 人工呼吸器を使って8人中7人亡くなっている計算。 「人工呼吸器付けないと死んでしまうけれど、付けてもほぼ助けられない」と捉える必要がある。 ECMOを付ければ魔法の様に治ったり、人工呼吸器付けたらどうにかなる、ではなさそう。この辺り、新聞テ…
RT @DrJohnScott: THREAD: Lots of alarm over the 🚨88% Mortality🚨among #Covid19 patients on ventilators. The paper *should* say "Among pts on…
RT @Pinboard: Rather than answer this a dozen times, I'll put it in the thread. The mortality statistic is from this paper. "Mortality for…
RT @JonPicciniSr: In-hospital mortality of #COVID19 in #NYC is 21%. Wow. To put that in perspective for #cardioTwitter 30-day mortality aft…
RT @MasuzoeYoichi: 最新の研究では、人工呼吸器を使用のコロナ患者の88.1%が死亡。つまり、人工呼吸器が必要になる前に、アビガンなどの抗ウイルス薬を早期に投与し治療効果を高めねばならないのである。第一線の医者からも、患者の命を救うためにアビガンを使用すべきだと…
人工呼吸器をつけた方の88.1%が亡くなっているって訳であってますかね? 使用段階に入ってる時点でまずいということになるので、前段階でアビガンなどの抗ワクチン剤入れた方が良いということなのか。 医療崩壊を進めたくないなら早めの投薬お願いします😷 https://t.co/ZEDLf5Dd1Q #コロナ https://t.co/tnRcv03fG6
RT @CyrilPedia: @Aiims1742 @MountSinaiNYC Pairs well with this, in JAMA https://t.co/2egJCoVgJK
RT @MasuzoeYoichi: 最新の研究では、人工呼吸器を使用のコロナ患者の88.1%が死亡。つまり、人工呼吸器が必要になる前に、アビガンなどの抗ウイルス薬を早期に投与し治療効果を高めねばならないのである。第一線の医者からも、患者の命を救うためにアビガンを使用すべきだと…
RT @onceuponA: I understand that journals are working on tight timetables to publish COVID research, but it boggles the mind that the sente…
RT @DrJohnScott: THREAD: Lots of alarm over the 🚨88% Mortality🚨among #Covid19 patients on ventilators. The paper *should* say "Among pts on…
RT @SteveSteinhubl: Report of largest cohort of hospitalized COVID-19 patients to date reinforcing what others have shown - fever at presen…
RT @CMichaelGibson: Outcomes in 5,700 hospitalized patients in New York. Overall mortality was 21%. 88% of those intubated died. https…
RT @MasuzoeYoichi: 最新の研究では、人工呼吸器を使用のコロナ患者の88.1%が死亡。つまり、人工呼吸器が必要になる前に、アビガンなどの抗ウイルス薬を早期に投与し治療効果を高めねばならないのである。第一線の医者からも、患者の命を救うためにアビガンを使用すべきだと…
RT @DrJohnScott: THREAD: Lots of alarm over the 🚨88% Mortality🚨among #Covid19 patients on ventilators. The paper *should* say "Among pts on…
誰にでも「表現の自由」があるので黙れとは思わないが、責任ある立場の人間として最低限確度の高い情報を共有し、事実と意見を混同しないでほしい。 いや、この方は今は大した責任もないから別にいいのか🤔? #DeepL https://t.co/NXcEO6mbT8
Interesting stats from NYC covid cases ... high % of ppl with high blood pressure, diabetes, etc... thx for sharing Dan!
RT @GringaBrazilien: Estudo de 5700 pacientes em 12 Hospitais de New York apresenta dados chocantes de Mortalidade COVID19: ENTUBADOS ✝️76%…
RT @DrJohnScott: THREAD: Lots of alarm over the 🚨88% Mortality🚨among #Covid19 patients on ventilators. The paper *should* say "Among pts on…
RT @covid_rehab: What are Clinical Characteristics, Comorbidities, and Outcomes Among Patients With COVID-19? [large case series with 5700…
Terrific thread about ventilators/Covid/ARDS/the difficulty of interpreting data on treatment of an emergent disease.
RT @ayako700: 【JAMA_ニューヨークの入院患者5700人の特徴、合併症、転帰】 4月22日JAMA論文をボランティアの方が日本語訳してくださいました https://t.co/ITE7148uZO COVID19 陽性で入院となった患者の来院時バイタルと採血…
3月1日から4月4日までのニューヨーク市内の12病院に入院した患者の既往歴や臨床的な背景のまとめですね。 Clinical Characteristics, Comorbidities, and Outcomes Among Patients With COVID-19 Hospitalized in the NYC Area https://t.co/Mmk2Rzi72K
RT @onceuponA: I understand that journals are working on tight timetables to publish COVID research, but it boggles the mind that the sente…
RT @DrJohnScott: THREAD: Lots of alarm over the 🚨88% Mortality🚨among #Covid19 patients on ventilators. The paper *should* say "Among pts on…
RT @CMichaelGibson: Outcomes in 5,700 hospitalized patients in New York. Overall mortality was 21%. 88% of those intubated died. https…
RT @JonPicciniSr: In-hospital mortality of #COVID19 in #NYC is 21%. Wow. To put that in perspective for #cardioTwitter 30-day mortality aft…
RT @IngridKatzMD: Thread: Whoa - this study from @JAMA_current is about as sobering as it gets. Recognize that it is a case series, and the…
RT @daltonprice386: [THREAD] Wow. A study published in @JAMA_current today with key numbers about #COVID19 in NYC area, n=5700 and all co…
RT @bclund: New report on 5700 NYC Covid patients: -94% had MORE than one other disease -Median age 63 -53% had hypertension -42% were obe…
People with diabetes, heart disease and/or obesity should take action NOW to improve metabolic health!!! https://t.co/Wa0y0xWgPc
RT @IngridKatzMD: Thread: Whoa - this study from @JAMA_current is about as sobering as it gets. Recognize that it is a case series, and the…
RT @SaskiaPopescu: And this is why we read the full article and not just the abstract. Thanks for calling out that bad practice @DrJohnScot…
RT @AndyBiotech: #COVID19 Important new data on 5700 hospitalized patients in NYC https://t.co/GiExjs8iFC median age 63 60% male 42% obes…
RT @daltonprice386: [THREAD] Wow. A study published in @JAMA_current today with key numbers about #COVID19 in NYC area, n=5700 and all co…
RT @SaskiaPopescu: And this is why we read the full article and not just the abstract. Thanks for calling out that bad practice @DrJohnScott
Outcomes for 2634 NY patients who died or were discharged by the study endpoint — supports what we’ve heard about ending up on a vent being a poor indication of survival
RT @MasuzoeYoichi: 最新の研究では、人工呼吸器を使用のコロナ患者の88.1%が死亡。つまり、人工呼吸器が必要になる前に、アビガンなどの抗ウイルス薬を早期に投与し治療効果を高めねばならないのである。第一線の医者からも、患者の命を救うためにアビガンを使用すべきだと…
RT @SaskiaPopescu: And this is why we read the full article and not just the abstract. Thanks for calling out that bad practice @DrJohnScott
RT @onceuponA: I understand that journals are working on tight timetables to publish COVID research, but it boggles the mind that the sente…
RT @SaskiaPopescu: And this is why we read the full article and not just the abstract. Thanks for calling out that bad practice @DrJohnScot…
RT @daltonprice386: [THREAD] Wow. A study published in @JAMA_current today with key numbers about #COVID19 in NYC area, n=5700 and all co…
RT @meganranney: A few key facts from this case series: 🔸️2% co-infection with another resp virus 🔸️21% mortality of all hospitalized pts…
RT @AbraarKaran: *New @JAMA_current* adding to hospitalized #covid19 outcomes literature 1/ -Among 5700 patients in NYC 2634 met study end…
RT @TomMcGinn4: New @JAMA_current: Largest US case series, 5700 NY #COVID inpatients at 12 Northwell hospitals fills gaps in COVID knowledg…
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area | Critical Care Medicine | JAMA | JAMA Network @MIUI| https://t.co/TGSEK2SxTD
RT @MasuzoeYoichi: 最新の研究では、人工呼吸器を使用のコロナ患者の88.1%が死亡。つまり、人工呼吸器が必要になる前に、アビガンなどの抗ウイルス薬を早期に投与し治療効果を高めねばならないのである。第一線の医者からも、患者の命を救うためにアビガンを使用すべきだと…
RT @MasuzoeYoichi: 最新の研究では、人工呼吸器を使用のコロナ患者の88.1%が死亡。つまり、人工呼吸器が必要になる前に、アビガンなどの抗ウイルス薬を早期に投与し治療効果を高めねばならないのである。第一線の医者からも、患者の命を救うためにアビガンを使用すべきだと…
RT @IngridKatzMD: Thread: Whoa - this study from @JAMA_current is about as sobering as it gets. Recognize that it is a case series, and the…
The Co-morbidty of Western Civilization, HTN, Obesity and DM increase risk for poor outcomes. @cupallcare @cuanschutz Clinical Characteristics, Comorbidities, and Outcomes Among Patients With COVID-19 Hospitalized in the NYC Area https://t.co/r4pkwAClC6
RT @DrJohnScott: THREAD: Lots of alarm over the 🚨88% Mortality🚨among #Covid19 patients on ventilators. The paper *should* say "Among pts on…
RT @MasuzoeYoichi: 最新の研究では、人工呼吸器を使用のコロナ患者の88.1%が死亡。つまり、人工呼吸器が必要になる前に、アビガンなどの抗ウイルス薬を早期に投与し治療効果を高めねばならないのである。第一線の医者からも、患者の命を救うためにアビガンを使用すべきだと…
RT @AbraarKaran: *New @JAMA_current* adding to hospitalized #covid19 outcomes literature 1/ -Among 5700 patients in NYC 2634 met study end…
RT @DrJohnScott: THREAD: Lots of alarm over the 🚨88% Mortality🚨among #Covid19 patients on ventilators. The paper *should* say "Among pts on…
And this is why we read the full article and not just the abstract. Thanks for calling out that bad practice @DrJohnScott
RT @EricTopol: Fixed link for @JAMA_current @NorthwellHealth paper https://t.co/13CeozQKlU by @SafiyaMD and colleagues
I understand that journals are working on tight timetables to publish COVID research, but it boggles the mind that the sentence "Mortality for those requiring mechanical ventilation was 88.1%." made it into the abstract when you have a fuller picture of th
RT @A_z_im: دیدید همه یکشبه داشتند ونتیلاتور اختراع می کردند. میانگین ۸۵ درصد کسانی که به ونتیلاتور نیاز پیدا می کنند می میرن.
Wow- JAMA series of NYC COVID patients is sobering. #COVID19 https://t.co/EiQJpOqBBS
RT @DrSamGirgis: In New York's largest healthcare system, #COVID19 patients requiring mechanical ventilation had 88% mortality rate... mor…
RT @jopo899: 5700 patient outcomes in New York https://t.co/7pvSgBTH65 #FOAMcovid
RT @H_Nobunaga: 出口としてはこれが一つだと思う。ただ、副作用が大きいことは覚悟しておく必要あり。膨大な使用はそもそも前提されている薬ではなかったと思う。治験でわかったリスクも国民に明らかにされることが重要。
RT @MasuzoeYoichi: 最新の研究では、人工呼吸器を使用のコロナ患者の88.1%が死亡。つまり、人工呼吸器が必要になる前に、アビガンなどの抗ウイルス薬を早期に投与し治療効果を高めねばならないのである。第一線の医者からも、患者の命を救うためにアビガンを使用すべきだと…
RT @DocWoc71: Conclusion: Among patients who were discharged or died (n = 2634), 14.2% were treated in the intensive care unit, 12.2% recei…
RT @TomMcGinn4: New @JAMA_current: Largest US case series, 5700 NY #COVID inpatients at 12 Northwell hospitals fills gaps in COVID knowledg…
RT @ryoma_tanaka: ニューヨーク市のコロナウィルス患者 人工呼吸器を要した患者の88%が死亡。かなり厳しい状況ですね。 https://t.co/DhLUPfjv1I
Amazing data .@DanRDimicco .@DavidBCollum .@wsmco .@cate_long
RT @DanCChamberlain: Of all the info to date, THIS is one of the most important studies!!! https://t.co/cm1gp9t3z0
RT @docmundele: Por favor si hacen estudios que incluyan tiempo de estancia hospitalaria presenten también promedios. Si bien desde un punt…